Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Interest income on loans | 63.5 | 60.8 | 58.9 | 55.0 | 52.5 | 51.1 | 53.1 | 53.7 |
Total interest income | 71.9 | 69.2 | 67.5 | 63.7 | 61.0 | 59.2 | 60.6 | 61.1 |
Total interest expense | 20.0 | 15.0 | 10.2 | 5.6 | 2.7 | 2.6 | 2.8 | 5.0 |
Net interest income | 51.9 | 54.2 | 57.3 | 58.1 | 58.3 | 56.6 | 57.8 | 56.1 |
Net interest income after provision for loan losses | 51.9 | 54.2 | 57.3 | 58.1 | 58.3 | 56.6 | 57.8 | 56.1 |
Deposit and loan fees | 1.6 | 1.7 | 1.9 | 1.9 | 1.8 | 1.8 | 1.8 | 1.6 |
Other non-interest income | 11.0 | 18.7 | 16.4 | 18.8 | 17.2 | 18.2 | 17.4 | 19.2 |
Total non-interest income | 12.6 | 20.4 | 18.4 | 20.7 | 18.9 | 20.0 | 19.2 | 20.9 |
Non-interest expenses | 52.0 | 50.2 | 50.2 | 49.6 | 49.1 | 46.8 | 48.2 | 50.2 |
Pre-tax income before non-recurring items | 10.9 | 25.7 | 24.5 | 28.4 | 27.7 | 30.5 | 25.4 | 28.3 |
Non-recurring items | 0.6 | 0.4 | 0.4 | 0.3 | 0.5 | 0.2 | 0.5 | 0.3 |
Pre-tax income | 10.3 | 25.3 | 24.1 | 28.1 | 27.2 | 30.3 | 24.9 | 28.0 |
Income taxes | 1.8 | 5.9 | 4.5 | 6.8 | 6.3 | 7.0 | 5.4 | 6.6 |
Tax rate | 17.3% | 23.3% | 18.6% | 24.1% | 23.2% | 23.0% | 21.7% | 23.7% |
Minority interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net income | 8.5 | 19.4 | 19.5 | 21.3 | 20.9 | 23.3 | 19.5 | 21.3 |
Net margin | 46.1% | 103.1% | 115.6% | 105.9% | 115.6% | 123.3% | 110.1% | 109.8% |
|
Basic EPS | $0.59 | $1.35 | $1.36 | $1.49 | $1.46 | $1.62 | $1.34 | $1.47 |
Diluted EPS | $0.59 | $1.35 | $1.36 | $1.49 | $1.45 | $1.61 | $1.33 | $1.46 |
|
Shares outstanding (basic) | 14.3 | 14.3 | 14.3 | 14.3 | 14.3 | 14.4 | 14.6 | 14.5 |
Shares outstanding (diluted) | 14.3 | 14.4 | 14.4 | 14.4 | 14.4 | 14.5 | 14.6 | 14.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|